The Society for Immunotherapy of Cancer (SITC) hosted "Concurrent Session II: Tumor Immunology 101 (Nurse/Pharmacist Track)" during the SITC 31st Annual Meeting & Associated Programs on November 11-13, 2016. Available here are the presentation slides and video from the session.Co-Chairs:
Advances in oncology drug development have led to the recent approval of novel immunotherapies. Given as monotherapy or in combination with other drugs or cancer treatment modalities, oncology providers must increase their knowledge in immunotherapy, as the mechanism of action, patient education, and adverse event management differs from chemotherapy and targeted therapy.
This session focused on the clinical management aspects of immunotherapy in oncology. Presentations by advanced practitioners provided an opportunity for attendees to improve clinical outcomes for individuals receiving immunotherapy through effective patient education, assessment, and management strategies of immune-related adverse events (ir-AEs).
Meeting: SITC 31st Annual Meeting; Session: Concurrent Session II: Clinical Management (Nurse/Pharmacist Track); Presenter: Brianna W. Hoffner, BA, MSN, RN, ANP-BC – University of Colorado Cancer Center; Date: November 12, 201600:13:47
Meeting: SITC 31st Annual Meeting; Session: Concurrent Session II: Clinical Management (Nurse/Pharmacist Track); Presenter: Krista M. Rubin, MS, FNP-BC – Massachusetts General Hospital Cancer Center; Date: November 12, 201600:20:10
Meeting: SITC 31st Annual Meeting; Session: Concurrent Session II: Clinical Management (Nurse/Pharmacist Track); Presenter: Kristen Kreamer, CRNP, MSN, AOCNP, APRN-BC – Fox Chase Cancer Center; Date: November 12, 201600:16:00
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us